On November 5, 2025, Zhejiang CDMO Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Bios-sincerity Pharmaceutical, received the CEP (Certificate of Suitability to Monograph of EuropeanPharmacopoeia) certificate for acetylcysteine issued by European Directorate for the Quality of Medicines & HealthCare (EDQM).

CEP Certificate一A Key Passport to the Intemational Market

CEP certificate (Certificate of Suitability to Monograph of European Pharmacopoeia), is a certification issued by EDQM that the quality of APIs conforms to the requirement of European Pharmacopoeia. This certificate is not only widely recognized by all EU member states, but also recognized by many countries that have signed bilateral agreements, such as Canada, Australia, and New Zealand. It is an important pass for

domestic API companies to enter the international market.

High-Standard R&D Drives Further Progress in Global Expansion

Zhejiang CDMO Pharmaceutical Co., Ltd., received the CEP certificate for acetylcysteine API is an important breakthrough for CDMO Pharmaceutical in international expansion. The high-standard and strict production and R&D concepts enabled the project to take only 14 months from registration application to successful approval, which fully reflects the team's professionalism and efficiency in quality management,R&D capabilities, international registration, and communication and collaboration.

In the future, the company will transform to a higher-end industrial chain, strengthen innovation-driven development, meet international registration needs, enhance global competitiveness, promote technological upgrades, further accelerate the pace of international business expansion, and provide global customers with higher quality products and services.

Zhejiang CDMO Pharmaceutical Co, Ltd.

Zhejiang CDMO Pharmaceuticals Co., Ltd. is an open, cooperative, and inclusive platform enterprise that integrates APIs and drug product, provides customers with high-quality and efficient CDMO/CMO services. The company covers the API platform, solid preparation platform, oral liquid preparation platform,injection platform, topical preparation platform, BFS eye drop platform, and BFS inhalation preparation

platform. Based on the cultural concept of innovative technology and serving health, the company promote the high-quality development of biopharmaceutical industry.